FDA Video - New Cellular Immunotherapy for Advanced Prostate Cancer
-
New Cellular Immunotherapy for Advanced Prostate Cancer
The FDA has approved a new therapy for certain men with advanced prostate cancer called Provenge (sipuleucel-T). Provenge, an autologous cellular immunotherapy, is manufactured by Dendreon Corporation. It is intended for men with asymptomatic or
Run Time: 1:23
Share this Video
Search Videos
Editor's Choice
FDA Basics: Norman Baylor
Run Time: 06:28
New Cellular Immunotherap
Run Time: 01:23
Health Fraud Awareness (C
Run Time: 02:43
Recently Added
Update on Rotarix Vaccine
Run Time: 06:24
What's New for the 2010-2
Run Time: 01:31
Life-Threatening Skin Rea
Run Time: 01:10
